|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
|
Fig. 2. Effect of the chloride channel inhibitor 9-carboxyanthracene (9-AC) on
[14C]oxalate uptake into hepatopancreatic BBMV. Vesicular and
incubation media contained 100 mmol l1 TMA-gluconate, 100
mmol l1 K-gluconate and 50 µmol l1
valinomycin, with (test) or without (control) 50 µmol l1
9-AC.
|